4
Changes in Ownership
Tarsus Pharmaceuticals, Inc. Filed Acc 0002162845-26-000005
Options or other derivatives
- Chief Commercial Officer acquired 17,265 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
Clase Neera · Chief Commercial Officer
Table II: Derivative
2 lines| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2026-11-03 | Grant or award : show line 1 in the form Stock Option (right to buy) | +10,587 | 10,587 | D |
| 2026-11-03 | Grant or award : show line 2 in the form Restricted Stock Units | +6,678 | 6,678 | D |
Loading xslF345X06/wk-form4_1793914818.xml…